Home / Generics

Generics

News

Celgene settles Revlimid patent litigation with Natco Pharma posted 09/02/2016

Celgene Corporation (Celgene) is to provide India-based Natco Pharma and its US partner, Arrow International – a unit of Alle...

FDA approval for generic antibiotic and arrhythmia drugs posted 01/02/2016

Indian generics maker Glenmark Pharmaceuticals (Glenmark) has gained approval for a generic antibiotic, linezolid, and tentat...

Roche and India's Glenmark reach truce over generic Tarceva posted 25/01/2016

The Swiss pharmaceutical company F. Hoffmann-La-Roche AG (Roche) has reached an out-of-court settlement with Indian generics...

Cipla, Glenmark, Sun Pharma bidding for Teva–Allergan generics in the US posted 08/01/2016

Indian generics makers Cipla, Glenmark Pharmaceuticals (Glenmark) and Sun Pharmaceutical Industries (Sun Pharma) are reported...

Dr Reddy’s faces temporary sales ban on generic esomeprazole posted 27/11/2015

A US court has temporarily banned Dr Reddy’s Laboratories from selling its generic version of AstraZeneca’s heartburn drug Ne...

 

Research

Pharmacists’ attitudes towards domestic generics in Afghanistan posted 29/01/2016

The aim of the study by Hassali et al. was to survey community pharmacists regarding their attitudes about the quality and pr...

Paediatric use of low-cost generic programs in the US posted 22/01/2016

Low-cost generic drug programs (LCGPs) in the US increase the affordability of prescription medication that can treat many co...

Physicians’ and pharmacists’ perspectives on generics use posted 18/01/2016

The review study of Toverud et al. shows that both physicians and pharmacists have acknowledged strategies for generics use a...

Use of generics in cardiovascular diseases posted 13/01/2016

Researchers from Italy and the US carried out a meta-analysis with the aim of comparing the efficacy and adverse events, eith...

Pharmaceutical pricing and reimbursement policies posted 14/12/2015

A recurrent challenge in health policy is to ensure equitable access to safe and effective medicines. In recent years, access...

 

General

Generics applications under review by EMA – December 2015 posted 09/02/2016

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

Proposed rebates will hit patients, not drug companies posted 28/01/2016

Attempts by US Congress to halt the rise in generics prices with new rebates payable by drugmakers has received a stinging re...

US politicians form Affordable Drug Pricing Task Force posted 28/01/2016

On 4 November 2015, democratic members of the House Committee on Oversight & Government Reform launched the Affordable Dr...

FDA making progress with ANDA backlog posted 28/01/2016

Despite an increase in the volume of abbreviated new drug application (ANDA) submissions, Type II API Drug Master Files (DMFs...

Brand-name drugmakers gain extra days of patent protection posted 28/01/2016

Brand-name drugmakers have gained some extra time, be it only days, for protection of their originator drugs after a ruling b...